Koselugo
Generic name: Selumetinib
Drug class:
Multikinase inhibitors
Usage of Koselugo
Koselugo inhibits the actions of an enzyme which is often activated in different types of cancers.
Koselugo is a prescription medicine used to treat neurofibromatosis (a genetic disorder that causes tumors to develop on the nerves) in children at least 2 years old.
Neurofibromatosis may cause tumors in the brain or spinal cord, learning disabilities, tumors on or under the skin, or bone deformities. Plexiform neurofibromas are large tumors that grow from nerves anywhere in the body and may become cancerous later in life.
Koselugo is for children with plexiform neurofibromas that cannot be surgically removed.
Koselugo side effects
Get emergency medical help if you have signs of an allergic reaction to Koselugo: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Diarrhea is a common side effect of this medicine. Tell your doctor right away the first time you have diarrhea while taking Koselugo.
Your doses may be delayed or permanently discontinued if you have certain side effects.
Common Koselugo side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Koselugo
Koselugo should not be given to a child younger than 2 years old.
Tell your doctor if your child has ever had:
A girl who has entered puberty may need to have a negative pregnancy test before starting this treatment.
Selumetinib can harm an unborn baby if the mother or father is using this medicine.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
Relate drugs
- Afatinib
- Alecensa
- Alectinib
- Alunbrig
- Avapritinib
- Ayvakit
- Cobimetinib
- Cotellic
- Crizotinib
- Balversa
- Binimetinib
- Braftovi
- Brigatinib
- Capmatinib
- Ceritinib
- Dabrafenib
- Deucravacitinib
- Encorafenib
- Entrectinib
- Erdafitinib
- Fedratinib
- Futibatinib
- Gavreto
- Gilotrif
- Gilteritinib
- Infigratinib
- Inrebic
- Jakafi
- Koselugo
- Larotrectinib
- Litfulo
- Lorbrena
- Lorlatinib
- Lytgobi
- Mekinist
- Mektovi
- Midostaurin
- Momelotinib
- Nintedanib
- Ofev
- Ojjaara
- Pacritinib
- Pemazyre
- Pemigatinib
- Pexidartinib
- Pralsetinib
- Qinlock
- Retevmo
- Ripretinib
- Ritlecitinib
- Rozlytrek
- Ruxolitinib
- Ruxolitinib (Oral)
- Rydapt
- Selpercatinib
- Selumetinib
- Sotyktu
- Tabrecta
- Tafinlar
- Tepmetko
- Tepotinib
- Trametinib
- Truseltiq
- Turalio
- Ukoniq
- Umbralisib
- Vemurafenib
- Vitrakvi
- Vonjo
- Xalkori
- Xospata
- Zelboraf
- Zykadia
How to use Koselugo
Usual Pediatric Dose for Fibromatosis:
2 years and older: 25 mg/m2 orally 2 times a day (approximately every 12 hours) until disease progression or unacceptable toxicity RECOMMENDED DOSE BASED ON BODY SURFACE AREA (BSA): -BSA less than 0.55 mg/m2: No dose recommendation. -BSA 0.55 to 0.69 m2: 20 mg/m2 orally in the morning and 10 mg/m2 in the evening -BSA 0.7 to 0.89 m2: 20 mg/m2 orally in the morning and 20 mg/m2 in the evening -BSA 0.9 to 1.09 m2: 25 mg/m2 orally in the morning and 25 mg/m2 in the evening -BSA 1.1 to 1.29 m2: 30 mg/m2 orally in the morning and 30 mg/m2 in the evening -BSA 1.3 to 1.49 m2: 35 mg/m2 orally in the morning and 35 mg/m2 in the evening -BSA 1.5 to 1.69 m2: 40 mg/m2 orally in the morning and 40 mg/m2 in the evening -BSA 1.7 to 1.89 m2: 45 mg/m2 orally in the morning and 45 mg/m2 in the evening -BSA 1.9 mg/m2 or greater: 50 mg orally in the morning and 50 mg/m2 in the evening Use: Treatment of pediatric patients 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
Warnings
Tell your healthcare provider if you are taking aspirin, blood thinners, or other medicines to treat blood clots. Koselugo contains vitamin E which may increase your risk of bleeding.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Koselugo
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Other drugs may interact with selumetinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions